Wail Alawi-Ba
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
PARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer.
Journal: Nature communications
Published: May 16, 2023
The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER+ breast cancer with mitotic aberrations.
Journal: Science advances
Published: September 07, 2022
Evaluation of statistical approaches for association testing in noisy drug screening data.
Journal: BMC bioinformatics
Published: October 18, 2021
PRMT inhibition induces a viral mimicry response in triple-negative breast cancer.
Journal: Nature chemical biology
Published: June 22, 2021
Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins.
Journal: Nature communications
Published: February 02, 2021
Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids.
Journal: Nature communications
Published: August 31, 2020
Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer.
Journal: Cancer discovery
Published: December 17, 2019
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer.
Journal: Nature communications
Published: August 08, 2019
PRMT5 inhibition disrupts splicing and stemness in glioblastoma.
Journal: Nature communications
Published: July 22, 2019
Creating reproducible pharmacogenomic analysis pipelines.
Journal: Scientific data
Published: April 17, 2019
Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts.
Journal: Cancer research
Published: January 31, 2019
Last Updated: 09/26/2026